Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
S2k-Leitlinie - Merkelzellkarzinom - Update 2022.
Becker JC, Beer AJ, DeTemple VK, Eigentler T, Flaig MJ, Gambichler T, Grabbe S, Höller U, Klumpp B, Lang S, Pföhler C, Posch C, Prasad V, Schlattmann P, Schneider-Burrus S, Ter-Nedden J, Terheyden P, Thoms K, Vordermark D, Ugurel S. Becker JC, et al. Among authors: schlattmann p. J Dtsch Dermatol Ges. 2023 Mar;21(3):305-317. doi: 10.1111/ddg.14930_g. J Dtsch Dermatol Ges. 2023. PMID: 36929546
S2k Guideline - Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - Update 2022.
Becker JC, Beer AJ, DeTemple VK, Eigentler T, Flaig M, Gambichler T, Grabbe S, Höller U, Klumpp B, Lang S, Pföhler C, Posch C, Prasad V, Schlattmann P, Schneider-Burrus S, Ter-Nedden J, Terheyden P, Thoms K, Vordermark D, Ugurel S. Becker JC, et al. Among authors: schlattmann p. J Dtsch Dermatol Ges. 2023 Mar;21(3):305-320. doi: 10.1111/ddg.14930. J Dtsch Dermatol Ges. 2023. PMID: 36929552
Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial.
Thomas-Rüddel D, Bauer M, Moita LF, Helbig C, Schlattmann P, Ehler J, Rahmel T, Meybohm P, Gründling M, Schenk H, Köcher T, Brunkhorst FM, Gräler M, Heger AJ, Weis S; EPOS-1 study group; SepNetCriticalCare TrialsGroup. Thomas-Rüddel D, et al. Among authors: schlattmann p. BMJ Open. 2024 Apr 22;14(4):e075158. doi: 10.1136/bmjopen-2023-075158. BMJ Open. 2024. PMID: 38653508 Free PMC article.
Understanding health care pathways of patients with sepsis: protocol of a mixed-methods analysis of health care utilization, experiences, and needs of patients with and after sepsis.
Fleischmann-Struzek C, Rose N, Ditscheid B, Draeger L, Dröge P, Freytag A, Goldhahn L, Kannengießer L, Kimmig A, Matthäus-Krämer C, Ruhnke T, Reinhart K, Schlattmann P, Schmidt K, Storch J, Ulbrich R, Ullmann S, Wedekind L, Swart E. Fleischmann-Struzek C, et al. Among authors: schlattmann p. BMC Health Serv Res. 2024 Jan 8;24(1):40. doi: 10.1186/s12913-023-10509-4. BMC Health Serv Res. 2024. PMID: 38191398 Free PMC article.
Metabolic Profiling Identifies 1-MetHis and 3-IPA as Potential Diagnostic Biomarkers for Patients With Acute and Chronic Heart Failure With Reduced Ejection Fraction.
Kretzschmar T, Westphal J, Neugebauer S, Wu JMF, Zeller M, Bogoviku J, Bekhite MM, Bekfani T, Schlattmann P, Kiehntopf M, Franz M, Schulze PC. Kretzschmar T, et al. Among authors: schlattmann p. Circ Heart Fail. 2024 Jan;17(1):e010813. doi: 10.1161/CIRCHEARTFAILURE.123.010813. Epub 2024 Jan 5. Circ Heart Fail. 2024. PMID: 38179791 Free PMC article.
Association between hospital onset of infection and outcomes in sepsis patients - A propensity score matched cohort study based on health claims data in Germany.
Rose N, Spoden M, Freytag A, Pletz M, Eckmanns T, Wedekind L, Storch J, Schlattmann P, Hartog CS, Reinhart K, Günster C, Fleischmann-Struzek C. Rose N, et al. Among authors: schlattmann p. Int J Med Microbiol. 2023 Nov;313(6):151593. doi: 10.1016/j.ijmm.2023.151593. Epub 2023 Dec 1. Int J Med Microbiol. 2023. PMID: 38070459 Free article.
287 results